Literature DB >> 17146371

T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women.

Alison J Quayle1, Athena P Kourtis, Susan Cu-Uvin, Joseph A Politch, Huixia Yang, Frederick P Bowman, Meha Shah, Deborah J Anderson, Peggy Crowley-Nowick, Ann Duerr.   

Abstract

BACKGROUND: The mucosal lymphocyte population is the largest in the body, and the gastrointestinal compartment has been well characterized in HIV infection. Much less is known about the effects of HIV on the genital tract.
OBJECTIVE: : To examine the T-lymphocyte phenotype and receptor repertoire as well as total and virus-specific immunoglobulin concentrations in the endocervix of HIV-infected women at different stages of infection as compared with uninfected women. PATIENTS AND METHODS: Participants were 12 seronegative women, 10 HIV-infected "slow progressors" not taking antiretroviral therapy, and 9 HIV-infected women whose antiretroviral therapy was failing. We used multiparameter flow cytometry to enumerate T-cell populations on cytobrush-obtained cervical specimens, the immunoscope technique to determine the T-cell receptor (TCR) repertoire, and quantitative enzyme-linked immunosorbent assays for antibody determinations on cervical secretions absorbed onto ophthalmic sponges. Nonparametric statistical analyses were performed.
RESULTS: We found marked depletion of leukocytes and CD4 T lymphocytes in the endocervix of HIV-infected women as compared with uninfected women; this was significant at more advanced disease stages. Naive T cells were rare in the endocervix of all groups. Activation marker expression was higher in endocervical T lymphocytes than in peripheral blood among control and slow-progressing HIV-infected women but not in women failing therapy. Endocervical T lymphocytes showed highly restricted utilization of Vbeta TCR families. Unlike other mucosal sites, the cervix contained IgG as the predominant immunoglobulin isotype. HIV-IgG was detected in the cervix of most HIV-infected women and in blood of all infected women.
CONCLUSIONS: HIV infection induces substantial changes in the immune profile of the female genital tract. Further study of the implications of these findings for HIV acquisition and transmission is needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17146371     DOI: 10.1097/QAI.0b013e31802c5b3a

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

1.  ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.

Authors:  Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

Review 2.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

3.  CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women.

Authors:  Amie L Meditz; Kerrie L Moreau; Samantha MaWhinney; Wendolyn S Gozansky; Kelsey Melander; Wendy M Kohrt; Margaret E Wierman; Elizabeth Connick
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

4.  Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe.

Authors:  Rebecca G Nowak; Patti E Gravitt; Charles S Morrison; Stephen J Gange; Cynthia Kwok; Amy E Oliver; Roslyn Howard; Barbara Van der Pol; Robert A Salata; Nancy S Padian; Tsungai Chipato; Marshall Munjoma; David D Celentano
Journal:  J Infect Dis       Date:  2011-04-15       Impact factor: 5.226

5.  Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.

Authors:  Amie L Meditz; Claire Palmer; Julie Predhomme; Kristina Searls; Becky Kerr; Sharon Seifert; Patricia Caraway; Edward M Gardner; Samantha MaWhinney; Peter L Anderson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-06-10       Impact factor: 2.205

6.  Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3).

Authors:  Tara Henning; Yetunde Fakile; Christi Phillips; Elizabeth Sweeney; James Mitchell; Dorothy Patton; Gail Sturdevant; Harlan D Caldwell; W Evan Secor; John Papp; R Michael Hendry; Janet McNicholl; Ellen Kersh
Journal:  J Med Primatol       Date:  2011-08       Impact factor: 0.667

Review 7.  Characteristics and quantities of HIV host cells in human genital tract secretions.

Authors:  Joseph A Politch; Jai Marathe; Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

8.  Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda.

Authors:  Kristine E Johnson; Mark E Sherman; Victor Ssempiija; Aaron A R Tobian; Jonathan M Zenilman; Maire A Duggan; Godfrey Kigozi; David Serwadda; Maria J Wawer; Thomas C Quinn; Charles S Rabkin; Ronald H Gray
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

9.  Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract.

Authors:  Nonhlanhla N Nkwanyana; Pamela P Gumbi; Lindi Roberts; Lynette Denny; Willem Hanekom; Andreia Soares; Bruce Allan; Anna-Lise Williamson; David Coetzee; Abraham J Olivier; Wendy A Burgers; Jo-Ann Passmore
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

10.  HIV Infection in Uncircumcised Men Is Associated With Altered CD8 T-cell Function But Normal CD4 T-cell Numbers in the Foreskin.

Authors:  Jessica L Prodger; Taha Hirbod; Ronald Gray; Godfrey Kigozi; Fred Nalugoda; Ronald Galiwango; Steven J Reynolds; Sanja Huibner; Maria J Wawer; David Serwadda; Rupert Kaul
Journal:  J Infect Dis       Date:  2013-11-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.